"Optimized combination of radiotherapy and immune therapies for treatment of solid tumors - biological rationale and challenges" - Prof. Dr. Udo Gaipl, Universitätsklinikum Erlangen
Einladung zur 10. CCI Lecture über "Optimized combination of radiotherapy and immune therapies for treatment of solid tumors - biological rationale and challenges" am 23.09.2024 um 16:00 Uhr im MZA Hörsaal.
Prof. Dr. rer. nat. habil. Udo Gaipl is Head of Radiation Immunobiology at Universitätsklinikum Erlangen (UKER). In 2003 he obtained his Dr. rer. nat. with ward and following a PostDoc time (2003-2005) at the Hospitale San Raffaele in Milano at the tumour immunology unit, he returned to Erlangen as group leader and continued his work on stressed cells as a tool for immune intervention. Since 2007 he heads the Radiation Immunobiology and is head of the Experimental Radiation Oncology of the German Society for Radiation Oncology (DEGRO). Since 2015 he his Professor for Experimental Medicine and has published more than 160 peer-reviewed papers on immune modulations by radiation and stressed cells. His papers are highly cited (h-index: 47) and his group significantly contributed to the paradigm shift that not only targeted effects of radiation on the DNA do exist, but also systemic and immune-mediated ones. The research focuses on immune modulation by activated, stressed and dying tumor cells, on radiation-induced stimulators and suppressor of the innate and adaptive immune system, on osteoimmunological modes of action of low radiation doses, on radioimmunotherapies, hyperthermia and immunophenotyping, as well as on translational clinical studies. He was WP leader of several EU funded projects and currently is key scientist and deputy head of a German research network dealing with the influence of exposure to low doses of radiation on the innate and adaptive immune system. Further he is commissioner and project leader of the DFG-Graduate School 1660 on Key Signals of Adaptive immune Responses and he heads a consortium funded by the Bayerische Forschungsstiftung on Multiscale Investigations of Hyperthermia as Additive Treatment Strategy for Solid Tumors.
zurück zur Übersicht